^
Association details:
Evidence:
Evidence Level:
Resistant: C3 ā€“ Early Trials
New
Title:

Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma

Excerpt:
Moreover, in the 168 cases treated with cetuximab in addition to basic treatment...56 showed a high expression of KLF4 in the nucleus that can cause poor prognosis of nasopharyngeal carcinoma (Pā€‰=ā€‰0.011).
DOI:
10.1186/s12967-018-1561-0